Phase II Trial of Methyl-gag and Melphalan in Metastatic Adult Renal Cell Carcinoma

Jose-Luis Guimaraes Medical Department, Institut Gustave-Roussy, Villejuif, France

Marwane Ghosn Medical Department, Institut Gustave-Roussy, Villejuif, France

Maurizio Ostronoff Medical Department, Institut Gustave-Roussy, Villejuif, France

Mohamed Azab Medical Department, Institut Gustave-Roussy, Villejuif, France

Christine Theodore Medical Department, Institut Gustave-Roussy, Villejuif, France

Jean-Pierre Droz Medical Department, Institut Gustave-Roussy, Villejuif, France

References

Sarosy G., Leylarrl-Jones B., Cheson B. D. The systemic administration of intravenous mlphalan. J Clin Oncol 1988; 6: 1768–1782
PubMed Web of Science ®Google Scholar
Knight W., Livingston R., Fabian D., et al. Phase I-II trial of methyl-gag: A Southwest Oncology Group pilot study. Cancer Treat Rep 1979; 63: 1933–1937
PubMedGoogle Scholar
Todd F., Garnick M., Canellos G., et al. Phase I-II trial of methylgag in the treatment of patients with metastatic renal adenocarcinoma. Cancer Treat Rep 1981; 65: 17–20
PubMedGoogle Scholar
Zeffren J., Yagoda A., Watson R., et al. Phase I-II trial of methylgag in advanced renal cancer. Cancer Treat Rep 1981; 65: 525–527
PubMedGoogle Scholar
Miller A. B., Hoogstraten B., Staquet M., et al. Reporting results of cancer treatment. Cancer 1981; 47: 207–214
PubMed Web of Science ®Google Scholar
Droz J. P., Theodore C., Ghosn M., et al. Twelve year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-Roussy. Sem Surg Oncol 1988; 4: 97–99
PubMed Web of Science ®Google Scholar
De Forges A., Rey A., Klink M., et al. Prognostic factors of adult metastatic renal carcinoma: a multivariate analysis. Sem Surg Oncol 1988; 4: 149–154
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Phase II Trial of Methyl-gag and Melphalan in Metastatic Adult Renal Cell Carcinoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Phase II Trial of Methyl-gag and Melphalan in Metastatic Adult Renal Cell Carcinoma

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date